92 related articles for article (PubMed ID: 3916620)
1. Controlled study on the use of hand-held insulin dosage computers enabling conversion to and optimizing of meal-related insulin therapy regimens.
Schrezenmeir J; Achterberg H; Bergeler J; Küstner E; Stümer W; Hutten H; Beyer J
Life Support Syst; 1985; 3 Suppl 1():561-7. PubMed ID: 3916620
[TBL] [Abstract][Full Text] [Related]
2. Computer assisted conventional insulin therapy.
Strack T; Bergeler J; Beyer J; Hutten H
Life Support Syst; 1985; 3 Suppl 1():568-72. PubMed ID: 3916621
[TBL] [Abstract][Full Text] [Related]
3. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
[TBL] [Abstract][Full Text] [Related]
4. Children and adolescents on intensive insulin therapy maintain postprandial glycaemic control without precise carbohydrate counting.
Smart CE; Ross K; Edge JA; Collins CE; Colyvas K; King BR
Diabet Med; 2009 Mar; 26(3):279-85. PubMed ID: 19317823
[TBL] [Abstract][Full Text] [Related]
5. [Intensified insulin therapy in type I diabetes: when and how?].
Martin S
Z Arztl Fortbild Qualitatssich; 1998 Sep; 92(7):475-80. PubMed ID: 9842692
[TBL] [Abstract][Full Text] [Related]
6. Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin.
Heinemann L; Heise T; Wahl LC; Trautmann ME; Ampudia J; Starke AA; Berger M
Diabet Med; 1996 Jul; 13(7):625-9. PubMed ID: 8840095
[TBL] [Abstract][Full Text] [Related]
7. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.
Ashwell SG; Gebbie J; Home PD
Diabet Med; 2006 Aug; 23(8):879-86. PubMed ID: 16911626
[TBL] [Abstract][Full Text] [Related]
8. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
[TBL] [Abstract][Full Text] [Related]
9. Does an insulin pen improve the metabolic control of type 1 diabetes mellitus if added to conventional treatment?
Roos AN; Meinders AE
Neth J Med; 1989 Apr; 34(3-4):116-25. PubMed ID: 2657451
[TBL] [Abstract][Full Text] [Related]
10. Minimal influence of the time interval between injection of regular insulin and food intake on blood glucose control of type 1 diabetic patients on a basal-bolus insulin scheme.
Scheen AJ; Letiexhe MR; Lefèbvre PJ
Diabetes Metab; 1999 Jun; 25(2):157-62. PubMed ID: 10443327
[TBL] [Abstract][Full Text] [Related]
11. [Continuous subcutaneous insulin infusion brings about normal blood sugar in type I diabetes mellitus despite relaxing of diet instructions].
Sonnenberg GE; Chantelau E; Altenähr H; Berger M; Berchtold P
Schweiz Med Wochenschr; 1982 Jan; 112(3):83-5. PubMed ID: 7036337
[TBL] [Abstract][Full Text] [Related]
12. Glycaemic control with modified intensive insulin injections (MII) using insulin pens and premixed insulin in children with type-1 diabetes: a randomized controlled trial.
Soliman AT; Omar M; Rizk MM; El Awwa A; AlGhobashy FM
J Trop Pediatr; 2006 Aug; 52(4):276-81. PubMed ID: 16410276
[TBL] [Abstract][Full Text] [Related]
13. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
14. [Liberalized diabetic diet for type I diabetics under intensive insulin injection therapy. Follow-up observations for over 2 years].
Chantelau E; Schmolke B; Gösseringer G; Hansen I; Berger M
Dtsch Med Wochenschr; 1985 Jul; 110(28-29):1119-24. PubMed ID: 3891292
[TBL] [Abstract][Full Text] [Related]
15. Run-to-run control of blood glucose concentrations for people with Type 1 diabetes mellitus.
Owens C; Zisser H; Jovanovic L; Srinivasan B; Bonvin D; Doyle FJ
IEEE Trans Biomed Eng; 2006 Jun; 53(6):996-1005. PubMed ID: 16761826
[TBL] [Abstract][Full Text] [Related]
16. Type 1 diabetes mellitus and the use of flexible insulin regimens.
Hirsch IB
Am Fam Physician; 1999 Nov; 60(8):2343-52, 2355-6. PubMed ID: 10593324
[TBL] [Abstract][Full Text] [Related]
17. Preprandial and postprandial variations of insulin sensitivity in different times of the day assessed by the artificial pancreas in type I diabetics.
Trovati M; Bruno A; Lorenzati R; Caselle MT; Pagani A; Gorzegno G; Pagano G
Chronobiologia; 1981; 8(4):333-40. PubMed ID: 7035094
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two intensified conventional insulin regimens with three and four daily injections.
Faglia E; Favales F; Brivio M; Calia P; Quarantiello A
Diabete Metab; 1993; 19(6):575-81. PubMed ID: 8026609
[TBL] [Abstract][Full Text] [Related]
19. Dietary adherence and associated glycemic control in families of young children with type 1 diabetes.
Patton SR; Dolan LM; Powers SW
J Am Diet Assoc; 2007 Jan; 107(1):46-52. PubMed ID: 17197270
[TBL] [Abstract][Full Text] [Related]
20. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
